Hearing rehabilitation by cochlear implantation is not always possible in case of total ossification after pneumococcal meningitis. We report 3 cases of postmeningitis profound hearing loss with total cochlear ossification in adults who underwent auditory brainstem implantation (Nucleus 22®, Cochlear Inc., Lane Cove, Australia) between 1999 and 2004. The postoperative follow-up period ranged from 1 to 6 years. Eleven to 15 out of 22 electrodes were activated. All patients had significant speech discrimination in the sound-only mode and an enhanced lip-reading performance with the implant. Auditory brainstem implants are an efficient means of auditory rehabilitation and may be considered in selected cases of bilateral profound hearing loss with the impossibility of cochlear implantation.

Keywords:
Pneumococcal meningitis, Hearing loss, Cochlear ossification, Auditory brainstem implant
1.
Balkany T, Bird PA, Hodges AV, Luntz M, Telischi FF, Buchman C: Surgical technique for implantation of the totally ossified cochlea. Laryngoscope 1998;108:988–992.
2.
Blamey PJ, Pyman BC, Gordon M, Clark GM, Brown AM, Dowell RC, Hollow RD: Factors predicting postoperative sentence scores in postlinguistically deaf adult cochlear implant patients. Ann Otol Rhinol Laryngol 1992;101:342–348.
3.
Colletti V, Carner M, Fiorino F, Sacchetto L, Miorelli V, Orsi A, Cilurzo F, Pacini L: Hearing restoration with auditory brainstem implant in three children with cochlear nerve aplasia. Otol Neurol 2002;23:682–693.
4.
Colletti V, Carner M, Miorelli V, Guida M, Colletti L, Fiorino F: Auditory brainstem implant (ABI): new frontiers in adults and children. Otolaryngol Head Neck Surg 2005;133:126–138.
5.
Colletti V, Fiorino FG, Carner M, Miorelli V, Guida M, Colletti L: Auditory brainstem implant as a salvage treatment after unsuccessful cochlear implantation. Otol Neurotol 2004;25:485–496.
6.
Colletti V, Shannon RV: Open set of speech perception with auditory brainstem implant? Laryngoscope 2005;115:1974–1978.
7.
Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21–28.
8.
Gibson WP, Rennie M, Psarros C: Outcome after cochlear implantation and auditory verbal training in terms of speech perception, speech production and language. Adv Otorhinolaryngol 2000;57:250–253.
9.
Grayeli AB, Bouccara D, Kalamarides M, Ambert-Dahan E, Coudert C, Cyna-Gorse F, Sollmann WP, Rey A, Sterkers O: Auditory brainstem implant in bilateral and completely ossified cochleae. Otol Neurotol 2003;24:79–82.
10.
Hinojosa R, Green JD, Marion MS: Ganglion cell populations in labyrinthitis ossificans. Am J OtoI 1991;12(suppl):3–7.
11.
Karino S, Hayashi N, Aoki S, Ohtomo K, Yamasoba T: New method of using reconstructed images for assessment of patency of intracochlear spaces for cochlear implant candidates. Laryngoscope 2004;114:1253–1258.
12.
Lenarz T, Lesinski-Schiedat A, Weber BP, Issing PR, Frohne C, Buchner A, Battmer RD, Parker J, von Wallenberg E: The nucleus double array cochlear implant: A new concept for the obliterated cochlea. OtoI Neurotol 2001;22:24–32.
13.
Nabili V, Brodie HA, Neverov NI, Tinling SP: Chronology of labyrinthitis ossificans induced by Streptococcus pneumoniae meningitis. Laryngoscope1999;109:931–935.
14.
Perrocheau A, Georges S, Laurent E: Epidemiology of bacterial meningitis in France in 2002. Rev Prat 2004;54:945–950.
15.
Portillo F, Nelson RA, Brackmann DE, Hitselberger WE, Shannon RV, Waring MD, Moore JK: Auditory brain stem implant: electrical stimulation of the human cochlear nucleus. Adv Otorhinolaryngol 1993;48:248–252.
16.
Rauch SD, Hermann BS, Davis LA, Nadol JB Jr: Nucleus 22 cochlear implantation results in postmeningitic deafness. Laryngoscope 1997;107:1606–1609.
17.
Toh EH, Luxford WM: Cochlear and brainstem implantation. Otolaryngol Clin North Am 2002;35:325–342.
18.
Young NM, Hughes CA, Byrd SE, Darling C: Postmeningitic ossification in pediatric cochlear implantation. Otolaryngol Head Neck Surg 2000;122:183–188.
© 2007 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.